Mark Jones

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Advanced Non Small Cell Lung Cancer

Newly Diagnosed

Tyrosine Kinase

Oxidative Stress

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Pamela N Munster, Nicholas O Iannotti, Daniel C Cho, Joanne M Jeter, Liza C Villaruz, Geoffrey Thomas Gibney, Frank Stephen Hodi, Niharika B Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven J O'Day
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study. Cancer research communications 3 (12) (2023)
Pamela N Munster, Nicholas O Iannotti, Daniel C Cho, Joanne M Jeter, Liza C Villaruz, Geoffrey Thomas Gibney, Frank Stephen Hodi, Niharika B Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven J O'Day
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study. Cancer research communications 3 (12) (2023)
Pamela N Munster, Nicholas O Iannotti, Daniel C Cho, Joanne M Jeter, Liza C Villaruz, Geoffrey Thomas Gibney, Frank Stephen Hodi, Niharika B Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven J O'Day
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study. Cancer research communications 3 (12) (2023)
Pamela N Munster, Nicholas O Iannotti, Daniel C Cho, Joanne M Jeter, Liza C Villaruz, Geoffrey Thomas Gibney, Frank Stephen Hodi, Niharika B Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven J O'Day
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study. Cancer research communications 3 (12) (2023)